The Claim
Among acute coronary syndrome patients who have achieved guideline-recommended LDL-C levels below 55 mg/dL, 16.4% experience major adverse cardiac and cerebrovascular events within one year, indicating that current lipid-lowering targets are insufficient to eliminate residual cardiovascular risk in this high-risk subgroup.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Even when acute coronary syndrome patients reach the lowest recommended LDL cholesterol levels, about 1 in 6 still suffer a serious heart or brain event within a year, showing that current cholesterol goals do not fully prevent future cardiovascular events in the highest-risk patients.
See the scientific wording
Despite achieving guideline-recommended LDL-C targets below 55 mg/dL, a substantial proportion (16.4%) of acute coronary syndrome patients experience major adverse cardiac and cerebrovascular events within one year, indicating that current lipid-lowering goals may not adequately address residual risk in the highest-risk subgroups.
Even when bad cholesterol is very low, the inside of blood vessels stays inflamed and damaged, causing clots to form and block arteries, leading to heart attacks or strokes.
What the research says
1 studyEven when heart attack patients get their bad cholesterol down to the lowest recommended level, more than 1 in 6 still have another serious heart or brain problem within a year—showing that just hitting the cholesterol target isn’t enough for the sickest patients.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.